Description
Glycosidase-IN-1 (Compound 9) is a glycosidase inhibitor synthesized from D-mannose. Glycosidase-IN-1 be used to synthesize some immunosuppressive agents and β-glucosidase inhibitors. Glycosidase-IN-1 has hypoglycemic activity.
Product information
CAS Number: 170376-12-2
Molecular Weight: 273.33
Formula: C13H23NO5
Chemical Name: tert-butyl (3aR,7R,7aS)-7-hydroxy-2,2-dimethyl-hexahydro-2H-[1,3]dioxolo[4,5-c]pyridine-5-carboxylate
Smiles: CC(C)(C)OC(=O)N1C[C@H]2OC(C)(C)O[C@H]2[C@H](O)C1
InChiKey: RPFDMDWEBWOMNO-BBBLOLIVSA-N
InChi: InChI=1S/C13H23NO5/c1-12(2,3)19-11(16)14-6-8(15)10-9(7-14)17-13(4,5)18-10/h8-10,15H,6-7H2,1-5H3/t8-,9-,10+/m1/s1
Technical Data
Appearance: Solid Power
Purity: ≥98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life: ≥12 months if stored properly.
Stock Solution Storage: 0 - 4 oC for 1 month or refer to the Certificate of Analysis.
Drug Formulation: To be determined
HS Tariff Code: 382200
How to use
In Vitro:
The synthesis of C5-mono-fluorinated piperidine iminosugar 3a commences with iminosugar Compound 8 that is prepared from D-mannose. In Scheme 2, protection of the ring nitrogen in Compound 8 using Boc-anhydride and Et3N gives Glycosidase-IN-1 (Compound 9).
Products are for research use only. Not for human use.
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.